Open AccessCLAZAKIZUMAB® (ANTI-IL-6) FOR DESENSITIZATION OF HIGHLY-HLA SENSITIZED PATIENTS AWAITING KIDNEY TRANSPLANT (NCT03380962)
Author(s) -
Ashley Vo,
Noriko Ammerman,
Edmund Huang,
Mieko Toyoda,
Shili Ge,
Alice Peng,
Reiad Najjar,
Summer Williamson,
C.N. Myers,
Supreet Sethi,
Kathlyn Lim,
Jua Choi,
Stanley C. Jordan
Publication year - 2020
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/01.tp.0000698796.63079.e4
Subject(s) - medicine , alemtuzumab , transplantation , desensitization (medicine) , gastroenterology , clinical endpoint , antibody , kidney transplantation , dialysis , human leukocyte antigen , immunology , antigen , clinical trial , receptor